Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Use this ABCL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ABCL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ABCL SEC filings page. Lician reads the product cache first so this HTML stays unique to Abcellera Biologics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ABCL income, balance, and cash tables.